Accendra Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Accendra Health, Inc. (ACH) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 2.49 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2026-02-20
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-12-31 was -2.48M shares.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-06-30 was 126.00K shares, a 21.15% increase year-over-year.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-03-31 was 2.36M shares.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2025 was 2.49K shares, a 143.55% increase from fiscal 2024.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2024 was 1.02K shares, a 47.35% decline from fiscal 2023.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2023 was 1.95K shares, a 99.93% decline from fiscal 2022.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2022 was 2.75M shares, a 0.47% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -2.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -2.48M shares derived: sum of 2 quarters · filed 2026-02-20 | -2.35M shares derived: sum of 3 quarters · filed 2026-02-20 | 2.49K shares 10-K · filed 2026-02-20 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | 126.00K shares derived: sum of 2 quarters · filed 2025-10-31 | 2.48M shares 10-Q · filed 2025-10-31 | 1.46M shares derived: sum of 4 quarters · filed 2026-02-20 | |
| 2025-06-30 | 126.00K shares 10-Q · filed 2025-08-11 | 2.48M shares 10-Q · filed 2025-08-11 | 1.46M shares derived: sum of 3 quarters · filed 2026-02-20 | 1.52M shares derived: sum of 4 quarters · filed 2026-02-20 | |
| 2025-03-31 | 2.36M shares derived: 10-K 12 month − 3 quarters · filed 2026-02-20 | 1.34M shares derived: sum of 2 quarters · filed 2026-02-20 | 1.39M shares derived: sum of 3 quarters · filed 2026-02-20 | 1.50M shares derived: sum of 4 quarters · filed 2026-02-20 | |
| 2024-12-31 | -1.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -964.98K shares derived: sum of 2 quarters · filed 2026-02-20 | -860.98K shares derived: sum of 3 quarters · filed 2026-02-20 | 1.02K shares 10-K · filed 2026-02-20 | 1.65M shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 55.00K shares 10-Q · filed 2025-10-31 | 159.00K shares derived: sum of 2 quarters · filed 2025-10-31 | 1.02M shares 10-Q · filed 2025-10-31 | ||
| 2024-06-30 | 104.00K shares 10-Q · filed 2025-08-11 | 966.00K shares 10-Q · filed 2025-08-11 | |||
| 2023-12-31 | 1.95K shares 10-K · filed 2026-02-20 | 3.14M shares 10-K · filed 2024-02-20 | |||
| 2022-12-31 | 2.75M shares 10-K · filed 2025-02-28 | ||||
| 2021-12-31 | 2.76M shares 10-K · filed 2024-02-20 | ||||
| 2020-12-31 | 2.29M shares 10-K · filed 2023-02-28 | ||||
| 2019-12-31 | 3.62M shares 10-K · filed 2022-02-23 | ||||
| 2018-12-31 | 2.25M shares 10-K · filed 2020-03-04 | 2.28M shares 10-K · filed 2019-03-06 | |||
| 2017-12-31 | 1.15M shares 10-K · filed 2019-03-06 | ||||
| 2016-12-31 | 572.00K shares 10-K · filed 2019-03-06 | ||||
| 2015-12-31 | 545.00K shares 10-K · filed 2018-02-23 | ||||
| 2014-12-31 | 371.00K shares 10-K · filed 2017-02-17 | ||||
| 2013-12-31 | 339.00K shares 10-K · filed 2016-02-25 | ||||
| 2012-12-31 | 298.00K shares 10-K · filed 2015-02-23 | ||||
| 2011-12-31 | 318.00K shares 10-K · filed 2014-02-25 | ||||
| 2010-12-31 | 317.00K shares 10-K · filed 2013-02-22 | ||||
| 2009-12-31 | 316.00K shares 10-K · filed 2012-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |